PTHLH and neoplasm: Aiming to block tumor expansion in bone, anti-resorptive approaches have been developed in cancer animal models, such as administration of bisphosphonates, i.e., zoledronic acid (ZA) or parathyroid hormone-related protein (PTHrP) neutralizing antibody (Guise et al. 1996; Sasaki et al. 1995).